These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 28094079)

  • 41. Neurotoxicity more likely in Hispanic children treated for acute lymphoblastic leukemia.
    Printz C
    Cancer; 2019 Feb; 125(4):494-495. PubMed ID: 30698835
    [No Abstract]   [Full Text] [Related]  

  • 42. Ex vivo activity of methotrexate versus novel antifolate inhibitors of dihydrofolate reductase and thymidylate synthase against childhood leukemia cells.
    Mauritz R; Bekkenk MW; Rots MG; Pieters R; Mini E; van Zantwijk CH; Veerman AJ; Peters GJ; Jansen G
    Clin Cancer Res; 1998 Oct; 4(10):2399-410. PubMed ID: 9796971
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Investigation on individualized adjustment of target range of high-dose methotrexate].
    Hua Y; Zhao WH; Lu XT; Yang LH; Lu W
    Zhonghua Er Ke Za Zhi; 2008 Mar; 46(3):203-8. PubMed ID: 19099710
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Digestive disease in the immunocompromised patient with acute lymphoblastic leukemia. Experience of the IVth Pediatric Clinic--Oncology Department of the Iaşi Sfânta Maria Children's Hospital].
    Moisă SM; Rusu A; Dumitraş S; Burlea M; Miron I
    Rev Med Chir Soc Med Nat Iasi; 2008; 112(2):356-65. PubMed ID: 19295004
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Methotrexate inhibits the glyoxalase system in vivo in children with acute lymphoid leukaemia.
    Bartyik K; Turi S; Orosz F; Karg E
    Eur J Cancer; 2004 Oct; 40(15):2287-92. PubMed ID: 15454255
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serum creatinine and creatinine clearance for predicting plasma methotrexate concentrations after high-dose methotrexate chemotherapy for the treatment for childhood lymphoblastic malignancies.
    Xu WQ; Zhang LY; Chen XY; Pan BH; Mao JQ; Song H; Li JY; Tang YM
    Cancer Chemother Pharmacol; 2014 Jan; 73(1):79-86. PubMed ID: 24158402
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recurrence of methotrexate-induced leukoencephalopathy after methotrexate rechallenge: A case report and literature review.
    AlKawi A; Hanbali A; Haj Aissa N; Mufti MA; Abdul Rab S
    Radiol Case Rep; 2023 Mar; 18(3):799-804. PubMed ID: 36582751
    [TBL] [Abstract][Full Text] [Related]  

  • 48. EEG with extreme delta brush in young female with methotrexate neurotoxicity supports NMDA receptor involvement.
    Schmidt LS; Kjær TW; Schmiegelow K; Born AP
    Eur J Paediatr Neurol; 2017 Sep; 21(5):795-797. PubMed ID: 28655493
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Safety and Efficacy of Aminophylline in Intrathecal Methotrexate-related Neurological Toxicity in Large Pediatric Oncology Centre.
    Razi W; Haque AU; Sadiq H; Ullah R; Jabbar N; Mirza S
    J Coll Physicians Surg Pak; 2021 Apr; 31(4):481-484. PubMed ID: 33866741
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Myelopathy mimicking subacute combined degeneration in a Down syndrome patient with methotrexate treatment for B lymphoblastic leukemia: report of an autopsy case.
    Satomi K; Yoshida M; Matsuoka K; Okita H; Hosoya Y; Shioda Y; Kumagai MA; Mori T; Morishita Y; Noguchi M; Nakazawa A
    Neuropathology; 2014 Aug; 34(4):414-9. PubMed ID: 24661121
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cognitive impairment persists at least 1 year after juvenile rats are treated with methotrexate.
    Wen J; Patel C; Diglio F; Baker K; Marshall G; Li S; Cole PD
    Neuropharmacology; 2022 Mar; 206():108939. PubMed ID: 34986414
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Polymorphisms in methylenetetrahydrofolate reductase and methotrexate sensitivity in childhood acute lymphoblastic leukemia.
    Taub JW; Matherly LH; Ravindranath Y; Kaspers GJ; Rots MG; Zantwijk CH
    Leukemia; 2002 Apr; 16(4):764-5. PubMed ID: 11960366
    [No Abstract]   [Full Text] [Related]  

  • 53. Acute methotrexate neurotoxicity with choreiform movements and focal neurological deficits: a case report.
    Bota DA; Dafer RM
    South Med J; 2009 Oct; 102(10):1071-4. PubMed ID: 19738521
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genetic and metabolic determinants of methotrexate-induced mucositis in pediatric acute lymphoblastic leukemia.
    den Hoed MA; Lopez-Lopez E; te Winkel ML; Tissing W; de Rooij JD; Gutierrez-Camino A; Garcia-Orad A; den Boer E; Pieters R; Pluijm SM; de Jonge R; van den Heuvel-Eibrink MM
    Pharmacogenomics J; 2015 Jun; 15(3):248-54. PubMed ID: 25348617
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Management of methotrexate-induced neurotoxicity with aminophylline plus dextromethorphan in a pediatric patient with pineoblastoma.
    Rubin MF; Kuhn AK
    Pediatr Blood Cancer; 2020 Dec; 67(12):e28515. PubMed ID: 32710710
    [No Abstract]   [Full Text] [Related]  

  • 56. Reduced folate carrier mutations are not the mechanism underlying methotrexate resistance in childhood acute lymphoblastic leukemia.
    Kaufman Y; Drori S; Cole PD; Kamen BA; Sirota J; Ifergan I; Arush MW; Elhasid R; Sahar D; Kaspers GJ; Jansen G; Matherly LH; Rechavi G; Toren A; Assaraf YG
    Cancer; 2004 Feb; 100(4):773-82. PubMed ID: 14770434
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The impact of high-dose methotrexate on intracellular 6-mercaptopurine disposition during interval therapy of childhood acute lymphoblastic leukemia.
    Adam de Beaumais T; Dervieux T; Fakhoury M; Medard Y; Azougagh S; Zhang D; Yakouben K; Jacqz-Aigrain E
    Cancer Chemother Pharmacol; 2010 Sep; 66(4):653-8. PubMed ID: 20033410
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Study on elimination delay in high dose methotrexate therapy in childhood acute lymphoblastic leukemia].
    Xu WQ; Tang YM; Fang CQ; Song H; Shi SW; Yang SL; Ren DT; Shen HQ; Qian BQ
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jan; 26(1):15-8. PubMed ID: 15946502
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Methotrexate-Induced Stroke-Like Syndrome: A Typical Presentation of a Rare Complication.
    Leitão Santos M; Silva S; Moreira A; Ribeiro A
    Cureus; 2023 Jun; 15(6):e40004. PubMed ID: 37416035
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A comparative study of the long term psychosocial functioning of childhood acute lymphoblastic leukemia survivors treated by intrathecal methotrexate with or without cranial radiation.
    Hill JM; Kornblith AB; Jones D; Freeman A; Holland JF; Glicksman AS; Boyett JM; Lenherr B; Brecher ML; Dubowy R; Kung F; Maurer H; Holland JC
    Cancer; 1998 Jan; 82(1):208-18. PubMed ID: 9428499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.